Edition:
United States

Evoke Pharma Inc (EVOK.OQ)

EVOK.OQ on NASDAQ Stock Exchange Capital Market

2.34USD
23 Apr 2018
Change (% chg)

$-0.06 (-2.50%)
Prev Close
$2.40
Open
$2.36
Day's High
$2.38
Day's Low
$2.34
Volume
2,002
Avg. Vol
15,577
52-wk High
$4.09
52-wk Low
$1.86

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.020
Sep '17 0.00 -0.342
Jun '17 0.00 -0.106
Mar '17 0.00 -0.373
FY 2016 Dec '16 0.00 -0.124
Sep '16 0.00 -0.285
Jun '16 0.00 -0.412
Mar '16 0.00 -0.450
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-18 3 0.00 0.00 0.00 18.95
Year Ending Dec-19 5 32.03 113.20 0.00 64.37
Earnings (per share)
Quarter Ending Jun-18 4 -0.16 -0.09 -0.25 -0.20
Quarter Ending Sep-18 4 -0.11 -0.05 -0.18 -0.18
Year Ending Dec-18 4 -0.56 -0.40 -0.84 -0.13
Year Ending Dec-19 5 -0.16 1.85 -0.97 0.55
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.21 32.78
P/E High - Last 5 Yrs. -- 40.52 45.94
P/E Low - Last 5 Yrs. -- 24.16 24.95
Beta 1.42 0.81 0.80
Price to Sales (TTM) -- 4.55 7.08
Price to Book (MRQ) 16.65 3.98 5.00
Price to Tangible Book (MRQ) 17.10 5.01 6.75
Price to Cash Flow (TTM) -- 22.71 25.60
% Owned Institutions 32.61 1.15 2.21

Dividends

  Company industry sector
Dividend Yield -- 1.65 1.55
Dividend Yield - 5 Year Avg -- 0.72 0.74
Dividend 5 Year Growth Rate -- 2.71 3.92
Payout Ratio(TTM) -- 20.05 20.28

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 6.88 9.00
Sales (TTM) vs TTM 1 Yr. Ago -- 9.72 10.85
Sales - 5 Yr. Growth Rate -- 7.67 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 83.80 19.15 22.25
EPS (TTM) vs TTM 1 Yr. Ago 33.80 -- --
EPS - 5 Yr. Growth Rate -- 8.95 10.24
Capital Spending - 5 Yr. Growth Rate -- 9.68 10.39

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.53 2.53
Current Ratio (MRQ) 3.82 3.62 3.62
LT Debt to Equity (MRQ) 0.00 8.58 11.28
Total Debt to Equity (MRQ) 0.00 10.89 13.94
Interest Coverage (TTM) -39.27 35.54 30.08

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.59 53.98
Gross Margin - 5 Yr. Avg. -- 52.05 52.10
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.40 15.94
Operating Margin (TTM) -- 12.92 4.32
Operating Margin - 5 Yr. Avg. -- 14.21 11.31
Pre-Tax Margin (TTM) -- 13.16 4.97
Pre-Tax Margin - 5 Yr. Avg. -- 14.56 11.62
Net Profit Margin (TTM) -- 9.57 1.58
Net Profit Margin - 5 Yr. Avg. -- 10.88 7.94
Effective Tax Rate (TTM) -- 22.53 31.27
Effective Tax Rate - 5 Yr. Avg. -- 23.67 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 925,307,828 819,537,692
Net Income/Employee (TTM) -1,747,073 108,821,662 96,346,718
Receivable Turnover (TTM) -- 5.62 5.57
Inventory Turnover (TTM) -- 2.56 3.45
Asset Turnover (TTM) 0.00 0.92 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -141.90 10.98 10.55
Return on Assets - 5 Yr. Avg. -81.15 12.18 11.58
Return on Investment (TTM) -177.89 13.61 13.21
Return on Investment - 5 Yr. Avg. -94.13 15.74 14.99
Return on Equity (TTM) -410.84 15.28 15.01
Return on Equity - 5 Yr. Avg. -177.24 16.91 16.27
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 28.68 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Evoke Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 32.61%
# of Holders: 35
Total Shares Held: 5,052,548
3 Mo. Net Change: -174
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 1
# Reduced Positions: 1
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.